SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 14th, 2017 • Mabvax Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 14th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 11, 2017, between MabVax Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).